Bär & Karrer advised BNP Paribas REIM, acting on behalf of one of its managed funds, on the sale of two investment properties located in Basel and St. Gallen to two institutional investors. The
Niederer Kraft Frey (NKF) advised EFG International on the acquisition of Quilvest (Switzerland), a pure-play Swiss private bank fully owned by Bemberg Capital. The closing of the transaction is expected in the third quarter of 2026
Bär & Karrer advised Euronext Paris-listed JCDecaux, as the globally active outdoor advertising company signed a share purchase agreement with NZZ, under which JCDecaux will sell 325,519 APG|SGA’s shares, corresponding to 10.85% of the
Homburger advised UBS Switzerland on the issuance, under the bank’s covered bond programme, of fixed rate covered bonds in the aggregate amount of CHF 685 million. Governed by Swiss law and listed on SIX Swiss
Homburger advised Zürcher Kantonalbank (ZKB) on the issuance of € 500 million 2.950 per cent. fixed rate bonds due January 26, 2031. The senior unsecured bonds in question have been issued under Zürcher Kantonalbank’s Swiss base prospectus.
Niederer Kraft Frey (NKF) advised SWISSto12 as the Swiss aerospace company secured EUR 73 million in financial support from European Space Agency (ESA) Member States through the HummingSat ARTES partnership project, aimed at producing a compact,
Baker McKenzie advised SFP Investment Foundation on all legal and tax aspects, and Copré on the tax aspects in connection with the establishment of a new, single-investor investment group for Copré, managed by SFP investment
Bär & Karrer advised UBS Switzerland in connection with the sale of its 50% stake in Swisscard to American Express Swiss Holdings. Previously, UBS and Swisscard had completed the transition of Swisscard’s Credit Suisse
Homburger advised Fastned Tico Holding I B.V., a direct subsidiary of electric fast-charging stations operator Fastned B.V., in connection with its role as borrower in a Dutch law-governed EUR 100 m committed senior multicurrency
European digital health company Oviva completed a USD 220m series D funding round, comprising a mix of primary and secondary capital. In connection with the operation, Lenz & Staehelin advised Oviva, Kellerhals Carrard represented existing
